Association Between Spending and Survival of Chronic Heart Failure Across Veterans Affairs Medical Centers

Authors:

Abstract
Chronic heart failure (CHF) is prevalent among 5% of US veterans in the Department of Veterans Affairs (VA) health care system,1 and annual mortality among those with CHF is 15%.2 The health care costs for patients with CHF are both high3 and highly variable in non-VA patient populations.4 High CHF expenditures are associated with both the high frequency of hospitalizations4 and the costs of testing, pharmacotherapy, devices, and chronic disease management programs.5 Small area variation in health care spending for the population of patients with CHF and others has been well documented,6-8 including variation in spending across the VA.9 Although comparisons of VA costs and outcomes in highly selected VA clinical populations have been previously reported,10 relatively little is known about whether and how the variation in health care spending among large patient populations with chronic disease across the VA is associated with the substantial variation in cardiovascular outcomes in these populations.1,11 In particular, it is unknown whether VA Medical Centers (VAMCs) with greater than average spending per veteran achieve better than average survival rates.

This publication has 26 references indexed in Scilit: